Actively Recruiting
Monitoring Minimal Residual Disease Using Tumor-Informed ctDNA Testing After Curative Surgery or Radiation for Squamous Cell Carcinoma of the Head, Neck, and Skin
Led by University of California, San Francisco · Updated on 2025-12-12
250
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how circulating tumor DNA ctDNA testing relates to cancer relapse in people with squamous cell carcinomas of the head, neck mucosa, and skin after they have undergone curative-intent surgery or radiation. This observational study aims to understand the rates of detectable ctDNA within two years after treatment and explore its association with outcomes like survival and recurrence. The study also looks at ctDNA presence at diagnosis and its relationship to tumor size seen in imaging. Participants will have tumor tissue samples collected at screening and blood samples taken before, during, and after their standard non-investigational cancer treatments, which include surgery or radiation therapy. Blood samples of about 20 mL each will be collected multiple times over up to two years to monitor ctDNA levels. The study does not involve experimental treatments but follows participants receiving standard care. During the study, researchers will review medical records for HPV testing and p16 staining as part of standard care. They will monitor ctDNA levels through blood samples and correlate these with imaging results and clinical outcomes like overall survival and disease-free survival. The main measure is the cumulative incidence rate of ctDNA detection over two years. Participants will be involved in regular sample collections and follow-up assessments throughout this period.
CONDITIONS
Brief Title
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
Research Team
S
Sonia Contreras Martinez
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here